132 related articles for article (PubMed ID: 9094979)
1. Cathepsin E expression by normal and premalignant cervical epithelium.
Mota F; Kanan JH; Rayment N; Mould T; Singer A; Chain BM
Am J Pathol; 1997 Apr; 150(4):1223-9. PubMed ID: 9094979
[TBL] [Abstract][Full Text] [Related]
2. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
4. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M; Ciotti M; Santini D; Bonito LD; Benedetto A; Giorgi C; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K;
Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
6. p16INK4A expression in cervical premalignant and malignant lesions.
Lambert AP; Anschau F; Schmitt VM
Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
[TBL] [Abstract][Full Text] [Related]
7. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Wang PH; Chen GD; Chang H; Yang SF; Han CP; Lin LY; Ko JL
Reprod Sci; 2007 May; 14(4):338-48. PubMed ID: 17644806
[TBL] [Abstract][Full Text] [Related]
8. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
9. The expression of histocompatibility antigen HLA-DR in cervical squamous epithelium infected with human papilloma virus.
Warhol MJ; Gee B
Mod Pathol; 1989 Mar; 2(2):101-4. PubMed ID: 2542929
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of aspartic proteinases and human leukocyte antigen-DR in human transplanted lung.
Arbustini E; Morbini P; Diegoli M; Grasso M; Fasani R; Vitulo P; Fiocca R; Cremaschi P; Volpato G; Martinelli L
Am J Pathol; 1994 Aug; 145(2):310-21. PubMed ID: 8053491
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cathepsin E expression during human B cell differentiation in vitro.
Sealy L; Mota F; Rayment N; Tatnell P; Kay J; Chain B
Eur J Immunol; 1996 Aug; 26(8):1838-43. PubMed ID: 8765029
[TBL] [Abstract][Full Text] [Related]
12. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.
Mota F; Rayment N; Chong S; Singer A; Chain B
Clin Exp Immunol; 1999 Apr; 116(1):33-40. PubMed ID: 10209502
[TBL] [Abstract][Full Text] [Related]
13. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
14. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling.
Sheets EE; Crum CP; Yeh J
Gynecol Oncol; 1996 Oct; 63(1):94-100. PubMed ID: 8898176
[TBL] [Abstract][Full Text] [Related]
15. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
Hughes RG; Norval M; Howie SE
J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
[TBL] [Abstract][Full Text] [Related]
16. Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes.
Coleman N; Greenfield IM; Hare J; Kruger-Gray H; Chain BM; Stanley MA
Am J Pathol; 1993 Aug; 143(2):355-67. PubMed ID: 8102029
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and cervical intraepithelial neoplasia as sexually transmitted diseases.
Sanz LE; Gurdian J
Semin Adolesc Med; 1986 Jun; 2(2):121-4. PubMed ID: 3037666
[No Abstract] [Full Text] [Related]
18. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia.
Coleman N; Stanley MA
Int J Cancer; 1994 Feb; 56(3):314-9. PubMed ID: 8314316
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions.
Viac J; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Immunobiology; 1993 Aug; 188(4-5):392-402. PubMed ID: 7503944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
